Similar results were obtained for the association between ALT (OR 1.04; 95% CI 1.02–1.07; P = 0.001), BMI (OR 1.43; 95% CI 1.24–1.64; P < 0.001), and NAFLD (Fig. 3b). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.